BIRC6 Modulates the Protein Stability of Axin to Regulate the Growth, Stemness, and Resistance of Renal Cancer Cells via the β‑Catenin Pathway

• Kaihua Zhong,
• Xiaohong Wang,
• Heyuan Zhang,
• Nanhui Chen,
• Yang Mai,
• Sipin Dai,
• Lawei Yang,
• Dong Chen,
• Weifeng Zhong

Affiliations

Kaihua Zhong

Department of Urology, Meizhou People’s Hospital, Meizhou, China

Xiaohong Wang

Department of Nephrology, Third Affiliated Hospital of Southern Medical University, Guangzhou, China

Heyuan Zhang

Department of Urology, Meizhou People’s Hospital, Meizhou, China

Nanhui Chen

Department of Urology, Meizhou People’s Hospital, Meizhou, China

Yang Mai

Department of Urology, Guangzhou Twelfth People’s Hospital, Guangzhou, China

Sipin Dai

Department of Urology, Guangzhou Twelfth People’s Hospital, Guangzhou, China

Lawei Yang

Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China

Dong Chen

Sun Yat-sen Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

Weifeng Zhong

Department of Urology, Meizhou People’s Hospital, Meizhou, China